Back

Correction to: HMGCoA reductase inhibition reverses myocardial fibrosis and diastolic dysfunction through AMP-activated protein kinase activation in a mouse model of metabolic syndrome

Cardiovascular Research

9 July 2020
Organised by: Logo
Read full article
ESC Journals
You may be interested in
thumbnail
Congress Presentation
Targeting cardiac remodeling and sirtuin gene expression in type 1 diabetes mellitus: role of dapagliflozin
31 August 2026
thumbnail
Congress Presentation
Myocardial tissue alterations in patients with alkaptonuria
30 August 2026
thumbnail
Congress Presentation
High fat diet rewires cardiac metabolism and restores cardiac function experimental heart failure
26 August 2023
thumbnail
Congress Presentation
Elucidating the role of Inositol 1,4,5-triphosphate receptors (IP3Rs) in modulating the regulation of cardiac myofibroblasts
11 May 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources